FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

 

 

Please select your country. This will keep you up to date with your country-specific information.

Reduced surgical invasiveness – enhance your patient’s benefits

Every day nearly 500 women are diagnosed with a gynaecological malignancy in Europe.1 Thanks to national screening programmes and regular check-ups, these cancers are often detected at an early stage.2-4 Even more luckily for these patients, the current clinical trend is moving toward less invasive surgical approaches which, combined with precision diagnostics, are leading to a great improvement in patient prognosis and quality of life.5-7

Sysmex supports innovation in healthcare with a cutting-edge solution.

  • Multiple patients could avoid unnecessary extended lymphadenectomies and related morbidities by implementing the sentinel lymph node biopsy concept.
  • You no longer need radioactive markers to detect sentinel lymph nodes as the Sentimag®/Magtrace® system detects them magnetically.

Literature

  1.  Ferlay J et al. (2013): Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 49(6):1374-403.
  2.  Vu M et al. (2018): Cervical cancer worldwide. Curr Probl Cancer. pii: S0147-0272(18)30134-X.
  3. Ogilvie G et al. (2017): Optimizing secondary prevention of cervical cancer: Recent advances and future challenges. Int J Gynaecol Obstet. 138 Suppl 1:15-19.
  4. Braun M et al. (2016): Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 93(6):468-74.
  5. Shisler R et al.(2018): Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecol Oncol. 148(2):403-413.
  6. Frost JA et al.(2017): Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 10:CD007585.
  7. Zigras T et al. (2017): Early Cervical Cancer: Current Dilemmas of Staging and Surgery. Curr Oncol Rep. 19(8):51.

Oncology

Oncology Report - New Customer Magazine

Watch Penny’s story
Watch video
Watch video
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Company movie